Sara Colombetti PhD

Sara Colombetti has received Ph.D. in Molecular and Cellular Biology at the San Raffaele Scientific Institute in Milan (Italy). After a post-doc in cancer immunotherapy at the Ludwig Institute for Cancer Research (Lausanne Branch) and later at Cytos Biotechnology (Zurich) She has joined the Roche Innovation Center Zurich (RICZ) in 2009, where she initially led the In Vivo Models team and then the Immuno-Pharmacodynamics and PK Unit. In 2017 she has been appointed Head of the Oncology Discovery Pharmacology at RICZ and in 2018 Global Head of Oncology Discovery Pharmacology.